Published by Josh White on 9th March 2021
(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Tuesday that its subsidiary Venn Life Sciences had been awarded a contract for a study with clinical-stage oncology company Oxford BioTherapeutics.
URL: http://www.digitallook.com/dl/news/story/31696684/...